BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 70 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $21,098,000 | +38.6% | 907,032 | 0.0% | 65.36% | +88.1% |
Q2 2022 | $15,220,000 | -62.2% | 907,032 | -1.1% | 34.74% | -28.5% |
Q1 2022 | $40,248,000 | -28.0% | 917,218 | -0.1% | 48.61% | +34.6% |
Q4 2021 | $55,888,000 | -6.5% | 918,154 | -36.1% | 36.13% | +23.6% |
Q3 2021 | $59,742,000 | +2.7% | 1,436,456 | -25.0% | 29.23% | +15.4% |
Q2 2021 | $58,147,000 | +1.6% | 1,915,274 | 0.0% | 25.33% | +18.2% |
Q1 2021 | $57,209,000 | +66.4% | 1,915,274 | 0.0% | 21.43% | +29.4% |
Q4 2020 | $34,379,000 | -5.8% | 1,915,274 | 0.0% | 16.56% | -10.4% |
Q3 2020 | $36,486,000 | +21.0% | 1,915,274 | 0.0% | 18.48% | -11.6% |
Q2 2020 | $30,147,000 | +15.3% | 1,915,274 | 0.0% | 20.91% | -4.6% |
Q1 2020 | $26,143,000 | +44.7% | 1,915,274 | 0.0% | 21.93% | +100.4% |
Q4 2019 | $18,061,000 | -17.2% | 1,915,274 | 0.0% | 10.94% | -28.6% |
Q3 2019 | $21,815,000 | +13.2% | 1,915,274 | 0.0% | 15.32% | +18.5% |
Q2 2019 | $19,268,000 | – | 1,915,274 | – | 12.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |